FinancialSpine

Spinal Fusion Device Market Anticipated to Surpass US$ 9.99 Billion by 2030 Driven by Innovations and Expanding Geriatric Demographics

Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) — The “Global Spinal Fusion Device Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

The global spinal fusion devices market is on track to achieve significant growth, with projections suggesting an increase in market size to US$ 9.99 Billion by 2030. This growth trajectory reflects a noteworthy compound annual growth rate (CAGR) of 3.98% between 2024 and 2030. A new comprehensive analysis highlights crucial insights and industry trends driving this expansion.

With an ever-increasing elderly population and rising incidences of spine-related disorders, the spinal fusion devices market is witnessing a consistent rise in demand. Advancements in medical technology have gradually extended the scope of spinal fusion surgery to treat a variety of conditions, leading to an upsurge in surgical procedures globally.

Industry Trends and Growth Drivers

  • Rising Geriatric Population: The aging demographic poses a high risk for spinal disorders, necessitating increased reliance on spinal fusion devices.
  • Technological Advancements: Continuous innovation including minimally invasive surgery techniques enhances the market demand for spinal fusion devices.
  • Prevalence of Spinal Conditions: With a high incidence of spinal cord injuries and related ailments, the need for efficient treatments is on the rise, propelling the market forward.

The market analysis delves into the different segments within the spinal fusion devices industry, including product types such as cervical devices, thoracolumbar devices, interbody devices, and biologics. The cervical segment is anticipated to witness substantial growth, propelled by technological advancements and increasing patient awareness.

Category Insights and Market Dynamics

  • Minimally Invasive Surgery: Dominating the market in revenue share, minimally invasive surgeries offer numerous benefits over traditional open spine surgery, thereby gaining preference among healthcare providers and patients.
  • Hospitals as Prime End-Users: Hospitals maintain the largest market share, accredited to their full range of services for spinal care and capacity for complex procedures.

Geographically, the Asia Pacific region is poised for a significant leap in the spinal fusion device market, with factors like an aging population, growing occurrences of road accidents, and advancements in healthcare infrastructure contributing to this growth.

Market Leaders and Innovators

  • Medtronic Plc
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Orthofix Medical Inc.
  • NuVasive Inc.
  • Globus Medical Inc.
  • Xtant Medical Holdings
  • Alphatec Holdings Inc.

The report offers an in-depth look at the present market scenario, encompassing a detailed company analysis that sheds light on the recent developments and revenue metrics of the industry’s leading players. These insights serve as crucial tools for stakeholders and market participants seeking to understand and navigate the evolving landscape of the spinal fusion device sector.

The comprehensive market analysis is a vital resource for those looking to grasp the full scope of the spinal fusion device industry, illustrating the dynamic interplay between technological innovations, market forces, and the growing demand due to demographic shifts. Such data underscores the potential of the spinal fusion device market to transform spine health treatment and improve patient outcomes significantly.


Key Attributes:

Report AttributeDetails
No. of Pages190
Forecast Period2023 – 2030
Estimated Market Value (USD) in 2023$7.6 Billion
Forecasted Market Value (USD) by 2030$9.99 Billion
Compound Annual Growth Rate3.9%
Regions CoveredGlobal

Report Segmentation

Product Type

  • Cervical Devices
  • Thoracolumbar Devices
  • Interbody Devices
  • Biologics

Surgery Type

  • Open Surgery
  • Minimally Invasive

End Users

  • Hospitals
  • Specialty Clinics
  • Others

For more information about this report visit https://www.researchandmarkets.com/r/rbvrrt

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button